• 17TH AUGUST 2022

    RPS wants your views on the future of pharmacy

    The Royal Pharmaceutical Society (RPS) wants to hear from pharmacy teams to help inform their work with The King’s Fund on the future of pharmacy practice in England. This work aims to set out a vision for the role of pharmacists and pharmacy teams working across all parts of the health and care system, providing

    Read more
    • 17TH AUGUST 2022

    Pharmacy bodies call on Government to protect pharmacists from violence at work

    PSNC, in collaboration with the Association of Independent Multiple Pharmacies, the Company Chemists’ Association, the National Pharmacy Association, and the Royal Pharmaceutical Society, is supporting an important petition calling for the Government and NHS leaders to act to keep pharmacists safe from violence and abuse. The petition was started by Mike Hewitson, a community pharmacist who has

    Read more
    • 17TH AUGUST 2022

    New NHSmail FAQs

    Since the recent launch of the NHS Profile Manager tool, which uses NHSmail accounts to allow pharmacy team members to login to it, both PSNC and the NHSmail team have received an increasing number of questions from pharmacy contractors regarding NHSmail. NHSmail is an NHS funded and managed secure email service which has been approved

    Read more
    • 17TH AUGUST 2022

    Reminder:  Update NHS website and DoS profile

    Community pharmacy contractors are reminded of the Terms of Service requirement to ensure they verify and, where necessary, update the information contained in their NHS website profile and their Directory of Services (DoS) profile at least once each quarter* of the financial year. For the current financial quarter, the deadline for completing this is 30th September 2022. Contractor

    Read more
    • 17TH AUGUST 2022

    MHRA Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets

    Class 4 Medicines Defect Information: Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets (Accord) Drug alert number: EL (22)A/35 Date issued: 17 August 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Rosuvastatin 5 mg film-coated tablets PL 20075/0402 Batch Number Expiry Date

    Read more
    • 16TH AUGUST 2022

    Flu vac: changes to training requirements for 2022/23

    Community pharmacy contractors are required to demonstrate that all vaccinators (including pharmacists) providing the flu vaccination service in their pharmacy have the skills needed to do so. From the 2022/23 flu vaccination season, pharmacists and other vaccinators providing the Flu Vaccination Service now only need to attend face-to-face training for both injection technique and basic

    Read more
    • 16TH AUGUST 2022

    Flu vac: service spec published

    The flu vaccination service specification has been published by NHS England; The national Patient Group Direction (PGD) and a national protocol to support provision of flu vaccinations will be published shortly; The service will commence on Thursday 1st September 2022; Training requirements have been updated to allow more flexibility for contractors and pharmacists; and Claims

    Read more
    • 16TH AUGUST 2022

    August 2022 Price Concessions 1st Update

    The Department of Health and Social Care (DHSC) has today (16/08/2022) granted the following initial list of price concessions: Drug Pack size Price concession Aciclovir 400mg tablets 56 £3.08 Alendronic acid 70mg tablets 4 £13.20 Amoxicillin 250mg/5ml oral suspension sugar free 100 £1.99 Brimonidine 0.2% eye drops 5 £5.11 Chlorpromazine 100mg tablets 28 £29.32 Citalopram

    Read more
    • 12TH AUGUST 2022

    Vaccine Supply Notification: Varicella vaccine (live) powder and solvent for suspension/solution for injection 0.5ml vials (Varivax® and Varilrix® )

    Department of Health and Social Care (DHSC) has issued a vaccine supply notification for Varicella vaccine (live) powder and solvent for suspension/solution for injection 0.5ml vials (Varivax® and Varilrix®). VSN/2022/001 Tier 2 – medium impact Date of issue 12th August 2022 Limited supplies of Varivax® and Varilrix® injection are available until mid-October 2022. A clinical

    Read more
    • 11TH AUGUST 2022

    Medicine Supply Notification: Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules. MSN/2022/069 Tier 2 – medium impact Date of issue 11th August 2022 Hydrocortisone sodium phosphate 100mg/1ml solution for injection ampoules are currently in very limited supply and stocks are likely to be exhausted

    Read more